Citadel Advisors’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.99M | Sell |
943,874
-2,065,515
| -69% | -$19.7M | ﹤0.01% | 1447 |
|
|
2025
Q1 | $31.5M | Buy |
3,009,389
+147,808
| +5% | +$1.55M | 0.01% | 662 |
|
|
2024
Q4 | $67.4M | Sell |
2,861,581
-77,759
| -3% | -$1.83M | 0.01% | 403 |
|
|
2024
Q3 | $106M | Sell |
2,939,340
-1,376,666
| -32% | -$49.4M | 0.02% | 220 |
|
|
2024
Q2 | $152M | Buy |
4,316,006
+61,730
| +1% | +$2.18M | 0.03% | 143 |
|
|
2024
Q1 | $121M | Buy |
4,254,276
+1,200,836
| +39% | +$34.1M | 0.02% | 195 |
|
|
2023
Q4 | $40.6M | Buy |
3,053,440
+11,834
| +0.4% | +$157K | 0.01% | 548 |
|
|
2023
Q3 | $27.3M | Buy |
3,041,606
+335,603
| +12% | +$3.01M | 0.01% | 663 |
|
|
2023
Q2 | $30.4M | Sell |
2,706,003
-322,797
| -11% | -$3.63M | 0.01% | 617 |
|
|
2023
Q1 | $34.9M | Buy |
3,028,800
+118,721
| +4% | +$1.37M | 0.01% | 595 |
|
|
2022
Q4 | $33.7M | Sell |
2,910,079
-12,293
| -0.4% | -$142K | 0.01% | 621 |
|
|
2022
Q3 | $37.1M | Sell |
2,922,372
-3,342
| -0.1% | -$42.4K | 0.01% | 522 |
|
|
2022
Q2 | $20.1M | Sell |
2,925,714
-36,619
| -1% | -$252K | 0.01% | 840 |
|
|
2022
Q1 | $28.6M | Buy |
2,962,333
+98,133
| +3% | +$946K | 0.01% | 693 |
|
|
2021
Q4 | $34.1M | Sell |
2,864,200
-9,477
| -0.3% | -$113K | 0.01% | 657 |
|
|
2021
Q3 | $46.7M | Sell |
2,873,677
-42,837
| -1% | -$696K | 0.01% | 484 |
|
|
2021
Q2 | $61.4M | Sell |
2,916,514
-179,066
| -6% | -$3.77M | 0.01% | 406 |
|
|
2021
Q1 | $48.1M | Sell |
3,095,580
-68,740
| -2% | -$1.07M | 0.01% | 486 |
|
|
2020
Q4 | $66.5M | Buy |
3,164,320
+195,927
| +7% | +$4.11M | 0.02% | 328 |
|
|
2020
Q3 | $59.9M | Buy |
+2,968,393
| New | +$59.9M | 0.02% | 332 |
|